Table 1 Baseline characteristics of the patients with ankylosing spondylitis.

From: Proposal of simplified CT syndesmophyte score (sCTSS) and comparison with CTSS in patients with ankylosing spondylitis

 

AS patients

(N = 50)

Male sex (N, %)

38 (76.0%)

Age (years)

33.5 [28.0–43.0]

Disease duration (years)

0.2 [0.0–1.0]

BMI (kg/m2)

23.8 [21.4–25.5]

Laboratory data

 ESR (mm/h)

8.0 [2.0–19.0]

 hs-CRP (mg/dL)

0.1 [0.1–0.7]

 HLA-B27 positive (N, %)

39 (78%)

Uveitis (N, %)

6 (12.0%)

Psoriasis (N, %)

1 (2.0%)

IBD (N, %)

0

Enthesitis (N, %)

5 (10.0%)

Peripheral arthritis (N, %)

13 (26%)

Dactylitis (N, %)

0

Medication

 NSAID (N, %)

48 (96.0%)

 Sulfasalazine (N, %)

34 (68.0%)

 Steroid (N, %)

10 (20.0%)

 TNFi (N, %)

5 (10.0%)

  1. Variables were presented as the median (interquartile range) or number (percentage).
  2. AS ankylosing spondylitis, BMI body mass index, ESR erythrocyte sedimentation rate, hs-CRP highly sensitive C-reactive protein, HLA human leukocyte antigen, IBD inflammatory bowel disease, NSAID non-steroidal anti-inflammatory drug, TNFi tumor necrosis factor inhibitor.
Back to article page